Eufloria Medical of Tennessee, Inc. leases 14-acre farm with 32,000 Sq/ft indoor growing area
NASHVILLE, Tenn., July 31, 2018 /PRNewswire/ -- Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB symbol: ACCA), an emerging cannabis company, through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ) and Eufloria Medical of Tennessee, Inc. (Eufloria) focused on the growing and distribution of new and proprietary medicinal hemp products for patients, USDA certified organic mobile processing and handling solutions for its customers, and technology solutions for the expanding physician market is pleased to announce that the company has secured a 14-acre farm with 32,000 square feet of indoor grow area in southern Tennessee. The company also acquired an option to purchase the farm, upon favorable terms, which option, Eufloria intends to exercise as soon as possible.
"We are pleased, for our shareholders, having the companies' first vertically integrated hemp operation in the state of Tennessee, allowing for improved efficiencies through growing, processing and manufacturing our own product line and building sales through dedicated distributors," said Richard K. Pertile, Acacia's Chief Executive Officer.
Richard K. Pertile, who has been overseeing the business of the company since January 14, 2016, states, "We are very excited to grow our own plant material, process that plant material through another wholly owned subsidiary, MariJ, and manufacture consumer products with the 'EUFLORIA' branding for the dedicated distribution channels."
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.